Heron Therapeutics HRTX 深 滬
等待開盤 11-04 09:30:00 美东时间
0.2847
-0.010
-3.52%
華盛通- 最 高0.3054
- 今 開0.293
- 成交量 104.10万股
- 最 低 0.279
- 昨 收 0.2951
- 總市值 5405.10万
- 52周最高 1.575
- 市盈率 靜 --
- 換手率 0.55%
- 52周最低 0.261
- 委 比 -99.43%
- 總股本 1.90亿
- 歷史最高 42.90
- 量 比 0.95
- 振 幅 8.95%
- 歷史最低 0.16
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Heron Therapeutics Inc.收涨6.27%，成交额35.37万美元
11月3日，Heron Therapeutics Inc.（HRTX）收涨6.27%，报0.3美元，成交额35.37万美元，市值5602.54万美元。 行情数据...
11-03 08:18
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Heron Therapeutics, Inc. will host a conference call and live webcast on November 9, 2026, at 8:30 a.m. ET to discuss third quarter financial results and recent business highlights. Participants can join via phone using a registration link or via webcast on Heron’s website. An archive will be available for 60 days. The company focuses on developing innovative therapies to improve patient care.
10-27 00:09
Heron Therapeutics Inc.收涨2.23%，成交额38.33万美元
10月24日，Heron Therapeutics Inc.（HRTX）收涨2.23%，报0.3美元，成交额38.33万美元，市值5748.7万美元。 行情数据...
10-24 07:22
Heron Therapeutics Inc.收跌4.12%，成交额62.34万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:18
Heron Therapeutics Expands U.S. Portfolio Through Licensing Deal
Heron Therapeutics ( ($HRTX) ) has provided an update. On September 23, 2026, H...
09-30 05:30
Heron Therapeutics Enters Multi-product Development And License Agreement On Sept 23, 2026; Granted Exclusive License To Market Products In U.S.; Co To Pay Milestone And Royalty Payments Under License Agreement
On September 23, 2026 (the "Effective Date"), Heron Therapeutics, Inc., a Delaware corporation (the "Company"), entered into a multi-product Development and License Agreement (the "License Agreement") with Long Grove Pharmaceuticals, LLC, a Delaware limited liability company ("Long Grove"), and Caps...
09-30 05:07
Heron Therapeutics Extends Tax Benefit Preservation Plan Timeline
The latest update is out from Heron Therapeutics ( ($HRTX) ). On August 13, 202...
08-15 05:18
HC Wainwright & Co. Downgrades Heron Therapeutics to Neutral
HC Wainwright & Co. analyst Brandon Folkes downgrades Heron Therapeutics (NASDAQ:HRTX) from Buy to Neutral.
08-11 20:31
Heron Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
Heron Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
08-11 02:00
美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
